Purchases and Sales Made in Q1 2023 in Diffusion Pharmaceuticals Inc. (DFFN)
This table provides information about the institutional ownership of Diffusion Pharmaceuticals Inc. (DFFN) during Q1 2023. The information is specifically focused on institutions that hold shares of Diffusion Pharmaceuticals Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
18.7KNew |
$77.4K - $123K
|
18.7K
$173K
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
512+ 18.23% |
$2.12K - $3.38K
|
3.32K
$30.7K
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
300+ 0.77% |
$1.25K - $1.98K
|
39.1K
$362K
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
147+ 45.51% |
$610 - $970
|
470
$4.35K
|
|
May 12, 2023
Q1 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
14+ 2.33% |
$58.1 - $92.4
|
614
$5.68K
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 16, 2024
Q1 2023
|
Connective Capital Management, LLC
Palo Alto, CA |
SELL
|
- |
-1Closed |
$4.15 - $6.6
|
0
$0
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-112- 88.89% |
$465 - $739
|
14
$130
|